MediciNova, Inc.
METHODS OF SUPPRESSING MYELOID-DERIVED SUPPRESSOR CELLS IN PATIENTS
Last updated:
Abstract:
Methods of suppressing myeloid-derived suppressor cells (MDSCs), reducing immune suppression, reducing regulatory T-cell count and increasing CD4+ T-cell count in cancer patients using ibudilast.
Status:
Application
Type:
Utility
Filling date:
31 Jul 2020
Issue date:
17 Jun 2021